Bank of New York Mellon’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-104,551
| Closed | -$248K | – | 4259 |
|
|
2024
Q1 | $248K | Sell |
104,551
-3,658
| -3% | -$8.67K | ﹤0.01% | 3854 |
|
|
2023
Q4 | $243K | Hold |
108,209
| – | – | ﹤0.01% | 3881 |
|
|
2023
Q3 | $229K | Hold |
108,209
| – | – | ﹤0.01% | 3907 |
|
|
2023
Q2 | $334K | Buy |
108,209
+95,964
| +784% | +$297K | ﹤0.01% | 3778 |
|
|
2023
Q1 | $65.9K | Hold |
12,245
| – | – | ﹤0.01% | 4138 |
|
|
2022
Q4 | $81.4K | Buy |
+12,245
| New | +$81.4K | ﹤0.01% | 4155 |
|
|
2022
Q2 | – | Sell |
-55,375
| Closed | -$335K | – | 4704 |
|
|
2022
Q1 | $335K | Sell |
55,375
-1,555
| -3% | -$9.41K | ﹤0.01% | 3951 |
|
|
2021
Q4 | $662K | Buy |
56,930
+4,679
| +9% | +$54.4K | ﹤0.01% | 3623 |
|
|
2021
Q3 | $819K | Buy |
52,251
+18,288
| +54% | +$287K | ﹤0.01% | 3512 |
|
|
2021
Q2 | $633K | Buy |
33,963
+3,822
| +13% | +$71.2K | ﹤0.01% | 3655 |
|
|
2021
Q1 | $1.3M | Buy |
+30,141
| New | +$1.3M | ﹤0.01% | 3185 |
|